OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of “Moderate Buy” by Analysts

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) have been given an average rating of “Moderate Buy” by the eleven analysts that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $23.8889.

KIDS has been the topic of several analyst reports. Lake Street Capital dropped their target price on OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, October 10th. Piper Sandler dropped their price objective on shares of OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating on the stock in a research note on Friday, October 10th. Canaccord Genuity Group started coverage on shares of OrthoPediatrics in a research note on Wednesday, December 10th. They issued a “buy” rating and a $24.00 target price for the company. Citigroup restated an “outperform” rating on shares of OrthoPediatrics in a research report on Friday, October 10th. Finally, JMP Securities lowered their target price on shares of OrthoPediatrics from $35.00 to $25.00 and set a “market outperform” rating on the stock in a research note on Friday, October 10th.

Institutional Trading of OrthoPediatrics

Institutional investors and hedge funds have recently made changes to their positions in the business. FourThought Financial Partners LLC purchased a new position in shares of OrthoPediatrics during the 4th quarter valued at approximately $197,000. Tudor Investment Corp ET AL lifted its holdings in OrthoPediatrics by 36.6% during the third quarter. Tudor Investment Corp ET AL now owns 70,935 shares of the company’s stock valued at $1,314,000 after purchasing an additional 19,004 shares in the last quarter. Nantahala Capital Management LLC acquired a new stake in shares of OrthoPediatrics in the third quarter valued at about $916,000. Millennium Management LLC increased its stake in shares of OrthoPediatrics by 20.8% during the third quarter. Millennium Management LLC now owns 943,655 shares of the company’s stock worth $17,486,000 after purchasing an additional 162,628 shares in the last quarter. Finally, Aquatic Capital Management LLC raised its position in shares of OrthoPediatrics by 149.7% during the 3rd quarter. Aquatic Capital Management LLC now owns 17,729 shares of the company’s stock worth $329,000 after purchasing an additional 10,629 shares during the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Price Performance

Shares of KIDS opened at $16.65 on Friday. The business’s 50-day moving average is $17.91 and its two-hundred day moving average is $18.56. The company has a market capitalization of $417.58 million, a P/E ratio of -8.54 and a beta of 1.12. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.52 and a current ratio of 7.40. OrthoPediatrics has a fifty-two week low of $15.28 and a fifty-two week high of $26.40.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.